"Development and Implementation of Novel Chatbot-based Genomic Research Consent".
Chatbot
Consent
Genetic counseling
Genetic research
Genetic testing
Journal
bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187
Informations de publication
Date de publication:
24 Jan 2023
24 Jan 2023
Historique:
pubmed:
8
2
2023
medline:
8
2
2023
entrez:
7
2
2023
Statut:
epublish
Résumé
To conduct a retrospective analysis comparing traditional human-based consenting to an automated chat-based consenting process. We developed a new chat-based consent using our IRB-approved consent forms. We leveraged a previously developed platform (Gia Engagement rates were similar between both consenting methods. The median length of the consent conversation was shorter for Gia users compared to traditional (44 vs. 76 minutes). Additionally, the total time from referral to consent completion was faster with Gia (5 vs. 16 days). Within Gia, understanding was assessed with a 10-question quiz that most participants (96%) passed. Feedback about the chat consent indicated that 86% of participants had a positive experience. Using Gia resulted in time savings for both the participant and study staff. The chatbot enables studies to reach more potential candidates. We identified five key features related to human-centered design for developing a consent chat. This analysis suggests that it is feasible to use an automated chatbot to scale obtaining informed consent for a genomics research study. We further identify a number of advantages when using a chatbot.
Identifiants
pubmed: 36747692
doi: 10.1101/2023.01.23.525221
pmc: PMC9900780
pii:
doi:
Types de publication
Preprint
Langues
eng
Déclaration de conflit d'intérêts
Competing Interests EDS, SKS, GMM, AHKK, and VAF are full time employees and stockholders of Invitae Corporation.